Literature DB >> 1527844

Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins.

O Rey1, D P Nayak.   

Abstract

We investigated the properties of ts51, an influenza virus (A/WSN/33) temperature-sensitive RNA segment 7 mutant. Nucleotide sequence analysis revealed that ts51 possesses a single nucleotide mutation, T-261----C, in RNA segment 7, resulting in a single amino acid change. Phenylalanine (position 79) in the wild-type M1 protein was substituted by serine in ts51. This mutation was phenotypically characterized by dramatic nuclear accumulation of the M1 protein and interfered with some steps at the late stage of virus replication, possibly affecting the assembly and/or budding of viral particles. However, although M1 protein was retained within the nucleus, export of the newly synthesized viral ribonucleoprotein containing the minus-strand RNA into the cytoplasm was essentially the same at both permissive and nonpermissive temperatures. The roles of M1 in the export of viral ribonucleoproteins from the nucleus into the cytoplasm and in the virus particle assembly process are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527844      PMCID: PMC241457     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Further isolation and characterization of temperature-sensitive mutants of influenza virus.

Authors:  A Sugiura; M Ueda; K Tobita; C Enomoto
Journal:  Virology       Date:  1975-06       Impact factor: 3.616

2.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

3.  Mechanism of influenza virus transcription inhibition by matrix (M1) protein.

Authors:  R W Hankins; K Nagata; A Kato; A Ishihama
Journal:  Res Virol       Date:  1990 May-Jun

4.  Transport of incoming influenza virus nucleocapsids into the nucleus.

Authors:  K Martin; A Helenius
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

5.  Composition of the helical internal components of influenza virus as revealed by immunogold labeling/electron microscopy.

Authors:  K G Murti; P S Brown; W J Bean; R G Webster
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

6.  Diversity and generation of defective interfering influenza virus particles.

Authors:  J M Janda; A R Davis; D P Nayak; B K De
Journal:  Virology       Date:  1979-05       Impact factor: 3.616

7.  Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.

Authors:  J P Chamberlain
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

8.  Differences in RNA patterns of influenza A viruses.

Authors:  P Palese; J L Schulman
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Identification of the defective genes in three mutant groups of influenza virus.

Authors:  M B Ritchey; P Palese
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

View more
  18 in total

1.  Restriction of viral replication by mutation of the influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus.

Authors:  G Whittaker; I Kemler; A Helenius
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

3.  Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons.

Authors:  G Whittaker; M Bui; A Helenius
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.

Authors:  Bin Zhou; Yan Li; Scott D Speer; Anju Subba; Xudong Lin; David E Wentworth
Journal:  Vaccine       Date:  2012-03-24       Impact factor: 3.641

5.  A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication.

Authors:  Shuai Cao; Xiaoling Liu; Maorong Yu; Jing Li; Xiaojuan Jia; Yuhai Bi; Lei Sun; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Attenuating mutations of the matrix gene of influenza A/WSN/33 virus.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Nucleus-targeting domain of the matrix protein (M1) of influenza virus.

Authors:  Z Ye; D Robinson; R R Wagner
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

8.  African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.

Authors:  E A Govorkova; G Murti; B Meignier; C de Taisne; R G Webster
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions.

Authors:  Sarah L Noton; Elizabeth Medcalf; Dawn Fisher; Anne E Mullin; Debra Elton; Paul Digard
Journal:  J Gen Virol       Date:  2007-08       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.